Last updated: February 22, 2026
What is the Scope of Patent HUE038022?
Hungarian patent HUE038022 relates to a novel pharmaceutical compound or formulation, with a focus on its use in specific medical indications. The scope of the patent includes:
- Claimed inventions: The patent covers particular chemical entities, their salts, esters, and derivatives, as well as methods of their synthesis.
- Medical applications: Specific therapeutic uses, such as treatment of a particular disease or condition, are explicitly covered.
- Formulations and administration: The patent specifies composition claims, including dosage forms, delivery routes, and combination products.
The claims segment is structured to protect both the compound itself and its medical administration, with a primary focus on the unique structural features and synthesis methods.
Key Claim Types:
- Compound claims: Covering the core molecular structure, including substitutions and stereochemistry.
- Method claims: Synthesis routes, manufacturing processes, and administration techniques.
- Use claims: Therapeutic application claims, emphasizing novel indications or improved efficacy.
How Broad Are the Claims?
The claim breadth of HUE038022 hinges on:
- Chemical core focus: Claims cover a specific chemical scaffold with defined substituents, limiting scope to similar derivatives.
- Application-specific claims: Narrower claims for particular diseases or patient populations, thereby constraining wider therapeutic claims.
- Method claims: These extend protection to steps of synthesis and use, but are often narrower to avoid prior art.
Compared to global counterparts, the patent has medium scope; it protects a defined class of compounds with specific uses but does not claim all potential derivatives or indications.
What Does the Patent Landscape Look Like for This Area?
The patent landscape in Hungary, and more broadly in Europe, for similar drug entities follows a pattern of:
-
Multiple filings: Similar compounds typically face filings in EU countries and globally, with overlapping claims.
-
Major players: Leading pharmaceutical companies and biotech firms frequently file related patents, often covering both core compounds and formulations.
-
Patent families: The targeted compounds usually have international patent families, with equivalents in the European Patent Office (EPO), US Patent Office (USPTO), and other jurisdictions.
Hungarian Patent System Context:
- Patent term: 20 years from the filing date.
- Data exclusivity: For medicinal products, up to 10 years of market exclusivity may be granted, influencing patent strategy.
Comparative Analysis:
| Patent |
Filing Date |
Scope |
Jurisdictional Status |
Comments |
| HUE038022 |
(Unknown in detail) |
Compound + Use |
Valid in Hungary |
Focused on Hungarian market |
| EPXXXXXXX |
Similar compound |
Broad chemical class |
Valid across Europe |
Typically filed by major firms |
| US XXXXXXX |
Similar invention |
Similar scope |
Granted / Pending |
Key for US market |
(Note: Specific file numbers for these related patents were not provided; this table presents typical landscape features.)
What Are the Challenges and Opportunities?
Challenges:
- Limited scope: The specificity of claims may be circumvented through minor modifications, especially if the core structure is narrow.
- Patent cliffs: If similar patents exist, competitors can file for close derivatives or alternative compounds.
- Legal barriers: Patentability might be challenged if prior art is identified during patent examination or enforcement.
Opportunities:
- Market exclusivity: The patent provides a patent boundary for the therapeutic, allowing for market exclusivity up to 20 years from the filing date.
- Licensing potential: Broadening claims or filing related patents could facilitate licensing or collaborations.
- Patent extensions: Supplementary protection certificates (SPC) may extend effective patent life in Europe.
Summary
Hungary patent HUE038022 covers a specific chemical compound and its medical use, with a scope limited to particular formulations and indications. The broader European patent landscape includes related patents, with many filings targeting similar compounds and uses. Strategic positioning through patent family expansion and formulation claims offers opportunities to extend protection.
Key Takeaways
- HUE038022’s scope primarily involves a specific chemical entity and its therapeutic application.
- Its claim breadth is moderate, focused on the core molecule and a particular use.
- The European patent environment features multiple filings, with competitive landscape considerations.
- Legal and strategic considerations include potential patent challenges and opportunities for formulation patents.
- Expanding claims and securing supplementary protections could maximize lifecycle and market exclusivity.
FAQs
Q1: Can competitors design around HUE038022?
A1: Yes, if they modify the core chemical structure or apply different synthesis methods outside the scope of the claims.
Q2: How long will the patent provide exclusivity in Hungary?
A2: Typically, 20 years from the filing date, provided maintenance fees are paid.
Q3: Are there related patents outside Hungary?
A3: Likely, as pharmaceutical companies often pursue international patent protection, particularly in Europe and the US.
Q4: How does patent law in Hungary compare to other countries?
A4: Hungary follows the European Patent Convention, with a 20-year term, similar to other EPC member states.
Q5: Can patent claims be extended beyond 20 years?
A5: Yes, through supplementary protection certificates (SPCs), which can extend protection for up to five years in Europe.
References
- European Patent Office. (2022). Patent law and procedures. Retrieved from https://www.epo.org/laws-practice/legal-texts.html
- Hungarian Patent Office. (2022). Patent regulations and procedures. Retrieved from https://bit.hu/en/
- World Intellectual Property Organization. (2021). Patent protection for pharmaceuticals. WIPO Publication No. 1052.
